Livorsi, DJ, Chorazy, ML, Schweizer, ML, et al. A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States. Antimicrob Resist Infect Control 2018;55:1–9.
Sader, HS, Huband, MD, Castanheira, M, et al.
Pseudomonas aeruginosa antimicrobial susceptibility results from four years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States. Antimicrob Agents Chemother 2017;61:1–7.
Barlam, TF, Cosgrove, SE, Abbo, LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016;62:e51–e77.
Lai, C, Shi, Z, Chen, Y, et al. Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common gram-negative bacilli causing health-care associated infections: a multicenter comparison. J Microbiol Immunol Infect 2016;49:74–82.
6. Lew, KY, Ng, TM, Tan, M, et al. Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting. J Antimicrob Chemother 2015;70:1219–1225.
Ahmad, F, Pogue, JM, Marchaim, D, et al. Evaluation of the potential impact of a carbapenem de-escalation program in an academic healthcare system. J Infect Public Health 2014;7:50–53.
8. Janssen, J, Kinkade, A, Man, D. Carbapenem utilization evaluation in a large community hospital (CARBON): a quality improvement study. Can J Hosp Pharm 2015;68:327–331.